Tag: AVXLD
The Buzz is Growing as $AVXL Moves Higher, Reversing the Trend
The Buzz only Get’s Bigger as $AVXL is now on Nasdaq and the Price Closes in on $15!
Buzz on $AVXL $AVXLD – Is StockGuru Behind This Momentum? Find Out Here!  #ANAVEX
Is $AVXL $AVXLD Moving Back Up Above $10? #Anavex Life Sciences Corp.
Our Coverage of $AVXL $AVXLD – Anavex Life Sciences Corp.  has been Extensive
Let’s Just Face it: The REAL Buzz is on $AVXLD $AVXL – Anavex Life Sciences Corp.
As $AVXL gets its D following Reverse $AVXLD – The Buzz is Bigger than Ever
Lot’s of Buzz coming from $CTIX – Cellceutix Corp.

CORRECTING and REPLACING — Anavex Prepares for Uplisting to NASDAQ, Announces Reverse Stock Split

NEW YORK, Oct. 06, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases, pain, and various types of cancer, today announced that it is finalizing an application to uplist trading of its common stock to…

Anavex Prepares for Uplisting to NASDAQ, Announces Reverse Stock Split

NEW YORK, Oct. 06, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases, pain, and various types of cancer, today announced that it is finalizing an application to uplist trading of its common stock to…

Most Talked About: AVXL – Up 18.44% Today

Anavex Completes Patient Enrollment for Phase 2a Alzheimer’s Trial Ahead of Schedule

NEW YORK, Sept. 28, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases, pain, and various types of cancer, today announced that patient enrollment for the Phase 2a clinical trial of ANAVEX 2-73 has…

Anavex to Present at 2015 Ladenburg Thalmann Healthcare Conference

NEW YORK, Sept. 23, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases, pain, and various types of cancer, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer, will present at…

LogMeIn's IoT Platform, Xively, Takes Top Honors at 2015 MassTLC Technology Leadership Awards

BOSTON, Sept. 22, 2015 (GLOBE NEWSWIRE) — LogMeIn Inc.’s (NASDAQ:LOGM) Internet of Things (IoT) platform, Xively, was named the IoT Innovative Technology of the Year winner by the Massachusetts Technology Leadership Council (MassTLC) during the 2015 Technology Leadership Awards. Xively offers management capabilities that help companies securely capture, analyze and manage data, while providing the…

Anavex Appoints International Alzheimer’s Expert to Scientific Advisory Board

NEW YORK, Sept. 21, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases, pain, and various types of cancer, today announced the appointment of Harald Hampel, MD, MA, PhD, MSc, to the Company’s Scientific…

Mice Model Market expected to reach USD 1.75 Billion by 2023: Transparency Market Research

Albany – NY, Sept. 9, 2015 (GLOBE NEWSWIRE) — According to a new market report published by Transparency Market Research “Mice Model Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023“, the global mice model market was valued at USD 1.01 billion in 2013 and is anticipated to expand at…

OraSure Technologies Announces 2016 Annual Meeting Date

BETHLEHEM, Pa., Aug. 28, 2015 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that its 2016 Annual Meeting of Stockholders is scheduled to be held on Tuesday, May 17, 2016. Further details regarding the meeting will be provided at a later date. About OraSure Technologies OraSure Technologies is a leader in the development, manufacture…

Patent Announcement  Spikes Volume in Anavex Life Sciences (AVXL)
Profile Stock Anavex Life Sciences (AVXL) Up 17% Today and 36% After Coverage Start
Profile Stock – Anavex Life Sciences Corp. (AVXL) Up 12.26% Intraday